Trial intelligence / Profile preview

Autologous blood treatment of collateral ventilation before endobronchial valve therapy in emphysema

NL-OMON23885Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Nov 2014
Countries
1
01

Overview

Open-label, single-arm trial of autologous blood in chronic obstructive pulmonary disease (COPD) and emphysema, sponsored by University Medical Center Groningen. Primary endpoint: Feasibility. Started Nov 2014; status: active, not recruiting.

02

Drugs

autologous blood
03

Conditions

chronic obstructive pulmonary disease (COPD)emphysema

Beyond the preview

Go deeper on NL-OMON23885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call